— Know what they know.
Not Investment Advice
Also trades as: ABBOTINDIA.BO (BSE) · $vol 0M

ABBOTINDIA.NS NSE

Abbott India Limited
1W: -0.1% 1M: +2.7% 3M: +3.6% YTD: -1.7% 1Y: -18.5% 3Y: +15.7% 5Y: +56.5%
₹26,225.00 ($272.39)
-615.00 (-2.29%)
 
NSE · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 53 · ₹570.5B mcap · 5M float · 0.194% daily turnover
Smart Money Score
Watch 0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹570.5B ($5.9B)
52W Range25135-30655
Volume6,879
Avg Volume10,051
Beta0.06
Dividend₹656.00
Analyst Ratings
No analyst coverage
Company Info
CEOKartik Rajendran
Employees3,749
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date2002-08-12
Godrej BKC
Mumbai, MA 400 051
IN
91 22 5046 1000
About Abbott India Limited

Abbott India Limited is a pharmaceutical enterprise that conducts its operations across India. The company provides an extensive portfolio of medicinal products designed for a broad spectrum of therapeutic areas, including women's health, digestive conditions, metabolic disorders, central nervous system ailments, pain management, premature labor concerns, vitamin supplementation, sleep aids, immunizations, and general consumer health items. Established in 1944, the firm was formerly known as Knoll Pharmaceuticals Limited until it officially adopted the name Abbott India Limited in July 2002. Headquartered in Mumbai, India, it operates as a subsidiary of Abbott Capital India Limited.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms